Answer
No. It is a hormone-regulating treatment. Selected prolonged-release products can also control growth of certain neuroendocrine tumours.
Sources for this answer
- Octreotide 50 micrograms/1 ml Solution for Injection — Current selected SmPCemc · Summary of Product Characteristics
- Olatuton 30 mg Powder and Solvent for Prolonged-release Suspension for Injection — Current selected SmPCemc · Summary of Product Characteristics
- Sandostatin LAR — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.